Claus Møldrup, DrugsDisclosed.com Founder and Former Professor in Social Pharmacy at the University of Copenhagen, turns the spotlight on diabetes and explores how to improve patient wellbeing and national health outcomes.
Open Access Government was privileged to speak with Dr Mary Stephen again, Public Health Expert at the World Health Organization African Region, about suppressing the spread of COVID-19, remaining vigilant and effectively tackling any resurgence.
Gary Lacasse, Executive Director with Kelly Puddister and Patrick Wright from the Canadian AIDS Society, argue that Canada is far behind other G7 countries in eliminating new HIV infections, with a 25.3% increase in new cases reported between 2014 and 2018.
Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.
Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.
Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.
Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.
Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill provides an informative introduction to E. coli and diarrheal disease.
Dr Lucy Chambers, Head of Research Communications at Diabetes UK, provides us with her thoughts on COVID-19 and diabetes, in terms of what do we (not) know.
Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
